Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVO

Novo Nordisk ADR

Dec 26 • 04:00PM ET

52.40

-0.16 -0.30 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI PID RVER WCMI AQEC APIE OZEM

Scroll to Statements

Index	-	P/E	15.26	EPS (ttm)	3.43	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	10.06%
Market Cap	176.52B	Forward P/E	14.90	EPS next Y	3.52	Insider Trans	-	Shs Float	3.37B	Perf Month	11.35%
Enterprise Value	187.32B	PEG	2.71	EPS next Q	0.92	Inst Own	9.03%	Short Float	0.85%	Perf Quarter	-5.77%
Income	15.29B	P/S	3.78	EPS this Y	15.66%	Inst Trans	-1.39%	Short Ratio	1.64	Perf Half Y	-23.51%
Sales	46.69B	P/B	8.71	EPS next Y	-3.83%	ROA	21.83%	Short Interest	28.49M	Perf YTD	-39.08%
Book/sh	6.02	P/C	34.42	EPS next 5Y	5.49%	ROE	68.30%	52W High	93.80 -44.14%	Perf Year	-40.93%
Cash/sh	1.52	P/FCF	17.65	EPS past 3/5Y	25.78% 21.74%	ROIC	37.50%	52W Low	43.08 21.63%	Perf 3Y	-20.72%
Dividend Est.	1.77 (3.38%)	EV/EBITDA	8.13	Sales past 3/5Y	23.46% 18.15%	Gross Margin	81.93%	Volatility	2.59% 2.32%	Perf 5Y	42.01%
Dividend TTM	1.73 (3.30%)	EV/Sales	4.01	EPS Y/Y TTM	11.24%	Oper. Margin	42.41%	ATR (14)	1.68	Perf 10Y	85.49%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.57	Sales Y/Y TTM	18.71%	Profit Margin	32.76%	RSI (14)	62.02	Recom	2.24
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	-21.84%	SMA20	7.08%	Beta	0.67	Target Price	60.01
Payout	35.93%	Debt/Eq	0.60	Sales Q/Q	11.80%	SMA50	5.78%	Rel Volume	0.75	Prev Close	52.56
Employees	76302	LT Debt/Eq	0.52	Earnings	Nov 05 BMO	SMA200	-13.11%	Avg Volume	17.32M	Price	52.40
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.41% -3.47%	Trades		Volume	12,967,837	Change	-0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral

Show Previous Ratings

Dec-26-25 02:56PM	Christmas Week Brings S&P 500 Records, Tech Volatility (Schaeffer's Research)
01:42PM	Should You Invest in Ozempic Maker Novo Nordisk in 2026? (Motley Fool)
12:42PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
12:41PM	Bear of the Day: Novo Nordisk (NVO) (Zacks)
12:05PM	GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds (GuruFocus.com)
10:10AM	Loading…
10:10AM	Stock Market Hits Record Highs On Nvidia, Google, GDP Data: Weekly Review (Investor's Business Daily)
08:01AM	Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access (GuruFocus.com)
Dec-25-25 12:05PM	Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? (Motley Fool)
09:00AM	As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? (Barchart)
06:40AM	Novo, Lilly race to cement lead in Indias obesity drug market, Reuters says (TipRanks)
12:47AM	Asian shares are mixed after US stocks drift to more records (Associated Press Finance)
Dec-24-25 05:46PM	Weight-loss pill approval spurs food industry overhaul (Reuters Videos)
05:45PM	Novo Nordisk (NVO) Rises Higher Than Market: Key Facts (Zacks)
10:49AM	NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly? (Zacks)
06:25AM	Novos Wegovy pill is planned to enter U.S. self-pay channels, Reuters says (TipRanks)
03:47AM	Loading…
03:47AM	Company News for Dec 24, 2025 (Zacks)
Dec-23-25 06:55PM	Closing Bell Movers: Novo Nordisk gains on Wegovy FDA update (TipRanks) +7.30%
06:17PM	Launch of Wegovy pill is core to Novo Nordisk's growth, says Guggenheim's Seamus Fernandez (CNBC TV)
06:00PM	Novo Nordisk says FDA approved Wegovy pill to reduce body weight (TipRanks)
05:23PM	Why Novo Nordisk Stock Popped Today (Motley Fool)
05:17PM	Dr. Ashish Jha talks Novo Nordisk getting approval for Wegovy pill (CNBC TV)
05:11PM	Stocks to Watch Tuesday Recap: Novo Nordisk, Huntington Ingalls, ServiceNow (The Wall Street Journal)
05:06PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:55PM	Heard on the Street Recap: A Dose of Optimism (The Wall Street Journal)
04:48PM	Stock Market Today: Dow Higher As S&P 500 Scores Record; Nvidia Clears Key Level (Live Coverage) (Investor's Business Daily)
04:41PM	How major US stock indexes fared Tuesday, 12/23/2025 (Associated Press Finance)
04:24PM	ServiceNow to acquire Armis for $7.75B, gold & silver record highs (Yahoo Finance Video)
04:15PM	These Stocks Moved the Most Today: Novo Nordisk, ServiceNow, Micron, DJT, Freeport-McMoRan, Zim, and More (Barrons.com)
04:05PM	Wegovy Pill Approval Sends Novo Nordisk Stock Soaring. What It Means for Eli Lilly. (Barrons.com)
04:03PM	Stock market today: S&P 500 notches latest 2025 record as Wall Street's winning streak reaches 4 (Yahoo Finance)
04:01PM	Loading…
04:01PM	Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug (Investor's Business Daily)
03:59PM	Stock Market Today: S&P 500 Eyes Record High; Analyst Names Reddit 2026 Top Pick (Live Coverage) (Investor's Business Daily)
03:16PM	Novo Nordisk is still worried about revenue growth next year despite obesity pill: BMO's Seigerman (CNBC TV)
02:51PM	These Stocks Are Moving the Most Today: Novo Nordisk, ServiceNow, Micron, DJT, Freeport-McMoRan, Zim, and More (Barrons.com)
02:24PM	Stock market today: S&P 500, Nasdaq, Dow turn higher after surprise GDP growth trims rate-cut bets (Yahoo Finance)
01:23PM	Novo Nordisk Strikes First With Oral Wegovy But Can It Outrun Lillys Looming Pill? (24/7 Wall St.)
01:04PM	Stock Market Today: Nasdaq Leads After GDP Surprise; Solar Stock Dives (Live Coverage) (Investor's Business Daily)
12:17PM	Arrival of GLP-1 weight-loss pill creates new headache for food, drink makers (Just Food)
11:37AM	Novo Jumps on Wegovy Pill Approval (GuruFocus.com)
11:33AM	FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk (CNBC TV)
11:31AM	Stock Market Today: Dow Edges Up; J&J Faces Order To Pay $1.5 Billion In Talc Lawsuit (Live Coverage) (Investor's Business Daily)
11:27AM	Novo Nordisk Loses Weight-Loss Lead as Lilly Gains Ground (GuruFocus.com)
10:46AM	Novo Nordisk Wins FDA Nod for Oral Wegovy in Obesity, Stock Up (Zacks)
10:38AM	Novo Nordisk Stock Soars on FDA-Cleared GLP-1 Pill (Schaeffer's Research)
10:36AM	Novo Nordisk Stock Soars After Weight-Loss Pill Approved in U.S. What It Means for Eli Lilly. (Barrons.com)
10:29AM	Why Eli Lilly Shares Are Down On Tuesday (GuruFocus.com)
10:15AM	Stock Market Today: Indexes Mixed After GDP Data Surprise; Alphabet Extends Gains (Live Coverage) (Investor's Business Daily)
10:14AM	Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? (Zacks)
09:52AM	Novo Nordisk Stock Sparks Massive Rally -- FDA Clears Wegovy Obesity Pill (GuruFocus.com)
09:48AM	Stock Market Today: Dow Slips After Strong GDP Data; Novo Soars On Weight-Loss Pill (Live Coverage) (Investor's Business Daily)
09:42AM	Novo Going 'All-In' With Wegovy Weight Loss Pill (Bloomberg)
09:39AM	Novo's GLP-1 pill gets approved, Trump Media stock pulls back (Yahoo Finance Video)
09:38AM	Stocks to Watch Tuesday: Novo Nordisk, Huntington Ingalls, ServiceNow (The Wall Street Journal)
09:11AM	Stock Market Today: Dow Falls After Surprise GDP Data; Novo Soars On Weight Loss Pill (Live Coverage) (Investor's Business Daily)
09:09AM	Stock futures, gold record high, FDA approves GLP-1 pill: 3 Things (Yahoo Finance Video)
09:07AM	Novo CEO Says Wegovy Pill Is Safe and Will Be Widely Available (Bloomberg)
07:35AM	ZIM, Novo Nordisk rise in premarket, space stocks fall (Investing.com)
07:05AM	Rising prices and weight-loss drugs are changing the way we eat - and food companies are racing to keep up (MarketWatch)
06:51AM	Markets Steady as Investors Await Final 2025 Data on Fed Rate Cuts (GuruFocus.com)
06:37AM	Novo beats Lilly to first FDA-approved GLP-1RA pill for obesity (Pharmaceutical Technology)
06:28AM	Novo Nordisk Jumps 7% After FDA Approves First Ever GLP-1 Pill (GuruFocus.com)
06:13AM	Rocket Labs loses altitude, and other early market movers (MarketWatch)
05:48AM	These Stocks Are Moving the Most Today: Novo Nordisk, Eli Lilly, Huntington Ingalls, Micron, DJT, Zim, and More (Barrons.com)
05:05AM	Novo Nordisk Shares Jump After FDA Approves Pill Version of Wegovy (The Wall Street Journal)
04:10AM	Novo Nordisk shares jump after FDA approves first GLP-1 weight-loss pill (Investing.com)
01:49AM	Novo Gets Approval to Sell Wegovy Obesity Pill in the US (Bloomberg)
12:48AM	Novo Nordisk wins US approval for weight-loss pill (Reuters Videos)
Dec-22-25 06:34PM	Stock market today: Dow, S&P 500, Nasdaq futures steady with S&P eyeing fresh record (Yahoo Finance)
06:29PM	Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss (Investing.com)
09:23AM	Lilly vs Novo Nordisk. Why 2026 Could Redefine the Obesity Drug Market (GuruFocus.com)
03:58AM	Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead? (Motley Fool)
Dec-21-25 03:00PM	While the price of 15 prescription drugs is set to drop, only 5.3M Americans will benefit. Here's what you need to know (Moneywise)
Dec-19-25 09:31PM	After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss (Benzinga)
05:40PM	Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump (Investor's Business Daily)
04:07PM	Lilly Shares Have Tripled on Weight-Loss Drugs. Why the Stock Looks Cheap. (Barrons.com)
02:53PM	?Novo Nordisk (NVO) Receives Positive Opinion For Wegovy By European Medicines Agency (Insider Monkey)
10:52AM	Did Eli Lilly Just Find the Holy Grail of Weight Loss? (24/7 Wall St.)
08:59AM	Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema (Zacks)
06:40AM	Eli Lillys oral GLP-1RA maintains weight loss from injectable drugs (Clinical Trials Arena)
06:01AM	Novo files for CagriSema approval; Merck and Pfizers trial win (BioPharma Dive)
Dec-18-25 09:20PM	Prediction: 1 Healthcare Giant Set to Soar in 2026 (Motley Fool)
05:14PM	Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound (CNBC TV)
04:36PM	Eli Lilly, IBD Stock Of The Day, Proves The Merit Of Its Weight-Loss Pill (Investor's Business Daily)
03:57PM	Obesity pill race heats up (CNBC TV)
01:55PM	Eli Lilly Obesity Pill Maintains Weight Loss After Wegovy, Zepbound (GuruFocus.com)
01:09PM	Lilly says obesity pill can replace shot after weight loss (Quartz)
11:54AM	Lose Weight on Zepbound, Keep It Off With Eli Lillys New Pill? Data Say That Works. (Barrons.com)
09:53AM	Can Higher-Dose Wegovy Help Novo Nordisk Regain Obesity Market Share? (Zacks)
09:49AM	Eli Lilly's Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study (Investor's Business Daily)
09:28AM	A new generation of weight-loss drugs is getting closer to patients. Here's how they differ from Wegovy and Zepbound. (MarketWatch)
09:20AM	Novo Nordisk (NVO) Fell Following a Profit Warning Release (Insider Monkey)
09:09AM	Wegovy Maker Novo Nordisk Files For FDA Approval of Obesity Drug CagriSema (The Wall Street Journal)
07:05AM	Better Buy in 2026: Novo Nordisk or Intuitive Surgical? (Motley Fool)
04:10AM	Better Pharmaceutical Buy: Eli Lilly vs. Novo Nordisk (Motley Fool)
Dec-17-25 05:45PM	Why Novo Nordisk (NVO) Dipped More Than Broader Market Today (Zacks)
05:12PM	UBS Reiterates Neutral on Novo Nordisk A/S (NVO) Despite Wegovy Dose Progress (Insider Monkey)
09:59AM	Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future? (Zacks)
08:57AM	Novo Nordisk (NVO) Hit By Lowered Guidance (Insider Monkey)
Dec-16-25 04:59PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:19PM	Why Pfizer's 2026 Guidance Miss Is 'Not A Major Surprise' (Investor's Business Daily)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience